Optimizing strategies to diagnose and control intestinal Schistosomiasis in low and moderate endemicity areas of Brazil

优化巴西低度和中度流行地区肠道血吸虫病的诊断和控制策略

基本信息

  • 批准号:
    MR/N017722/1
  • 负责人:
  • 金额:
    $ 11.54万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2016
  • 资助国家:
    英国
  • 起止时间:
    2016 至 无数据
  • 项目状态:
    已结题

项目摘要

Over 200 million people suffer with the disease Schistosomiasis which is caused by the presence in the human blood vessels of trematode worms of the genus Schistosoma. This leads to long term disability and can be fatal. Therefore, intestinal and urinary schistosomiasis are considered serious public health problems in vast regions of Africa, Asia and Latin America. The current mainstream diagnostic method for intestinal schistosomiasis is the detection of eggs in stool by Kato-Katz. This method, however, is limited costly, time-consuming, and may be particularly unreliable where there is low levels of infection, as would be expected after several rounds of treatment or in regions where transmission is low. In order to overcome some of the pitfalls of this diagnostic method, there has been interest in developing new and more sensitive tests for the diagnosis of schistosomiasis. Antigen detection in urine (CCA) has been documented to be a sensitive and specific alternative to Kato-Katz in several moderate and high endemnicity settings. Data comparing the performance of stool microscopy (Kato-Katz) and a urine dipstick (CCA) in low Schistosomiasis prevalence settings, however, is currently lacking. In this context, the aim of this project is to compare the performance of CCA with Kato-Katz in the low endemic area of Minas Gerais State, and in a moderate endemic area of Sergipe State Brazil. Furthermore, the study aims to enhance knowledge of the spatial distribution of schistosomiasis in Brazil that will assist planning of the preventive chemotherapy strategy for the national schistosomiasis control programme.
超过2亿人患有血吸虫病,这是由血吸虫属蠕虫在人体血管中的存在引起的。这会导致长期残疾,并可能致命。因此,在非洲、亚洲和拉丁美洲的广大地区,肠道和泌尿系统血吸虫病被认为是严重的公共卫生问题。目前肠血吸虫病的主流诊断方法是Kato-Katz检测粪便中的虫卵。然而,这种方法是有限的,昂贵的,耗时的,并且在感染水平低的情况下可能特别不可靠,正如在几轮治疗后或在传播率低的地区所预期的那样。为了克服这种诊断方法的一些缺陷,人们一直有兴趣开发新的和更敏感的血吸虫病诊断测试。尿液中的抗原检测(CCA)已被证明是一个敏感和具体的替代加藤Katz在几个中度和高度流行的设置。然而,目前缺乏比较粪便显微镜检查(Kato-Katz)和尿试纸(CCA)在血吸虫病低流行环境中的性能的数据。在这种情况下,本项目的目的是比较的性能CCA与卡托-卡茨在低流行地区的米纳斯吉拉斯州,并在中度流行地区的塞尔吉佩州巴西。此外,该研究旨在提高巴西血吸虫病的空间分布的知识,这将有助于规划国家血吸虫病控制方案的预防性化疗战略。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Discrepancy between batches and impact on the sensitivity of point-of-care circulating cathodic antigen tests for Schistosoma mansoni infection
  • DOI:
    10.1016/j.actatropica.2019.105049
  • 发表时间:
    2019-09-01
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Viana, Agostinho Goncalves;Gazzinelli-Guimaraes, Pedro Henrique;Fujiwara, Ricardo Toshio
  • 通讯作者:
    Fujiwara, Ricardo Toshio
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna Phillips其他文献

Team Teaching Technical Topics: An Innovative Approach To Instruction In An Introductory Civil Engineering Course
团队教学技术主题:土木工程入门课程的创新教学方法
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Charles V. Camp;Anna Phillips;P. Palazolo
  • 通讯作者:
    P. Palazolo
Health and social services for pregnant and parenting high risk teens
为怀孕和养育高危青少年提供健康和社会服务
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Rosemary C. Sarri;Anna Phillips
  • 通讯作者:
    Anna Phillips
A multicentre prospective study of exocrine pancreatic insufficiency at 3 months after acute pancreatitis attack
急性胰腺炎发作后 3 个月外分泌胰腺功能不全的多中心前瞻性研究
  • DOI:
    10.1016/j.pan.2023.06.461
  • 发表时间:
    2023-11-05
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Anna Phillips;Joseph Bejjani;Jennifer Chennat;Peter Lee;Jorge Machicado;Vikesh Singh;Elham Afghani;Phil Hart;Mitchell Ramsey;Pedram Paragomi;Kimberly Stello;Stacey Culp;Georgios Papachristou
  • 通讯作者:
    Georgios Papachristou
A systems biology approach towards understanding nuclear receptor interactions: Implications at the endocrine–xenobiotic signalling interface
  • DOI:
    10.1016/j.tox.2011.09.054
  • 发表时间:
    2011-12-18
  • 期刊:
  • 影响因子:
  • 作者:
    Alexey N. Kolodkin;Anna Phillips;Steve Hood;Frank J. Bruggeman;Hans V. Westerhoff;Nick Plant
  • 通讯作者:
    Nick Plant
Use of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Agents for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis
  • DOI:
    10.1182/blood-2022-170853
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Ali Eshaghpour;Rachel Foote;Anna Phillips;Shreyas Sreeraman;Allen Li;Mark Crowther
  • 通讯作者:
    Mark Crowther

Anna Phillips的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    合作创新研究团队
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
  • 批准号:
    82373299
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
面向人工智能生成内容的风险识别与治理策略研究
  • 批准号:
    72304290
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Innovative Double Patterning Strategies for Integrated Circuit Manufacture
集成电路制造的创新双图案化策略
  • 批准号:
    LP230100313
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Linkage Projects
Gender Affirmation in Childhood: Protective Factors and Strategies
童年时期的性别肯定:保护因素和策略
  • 批准号:
    DP240101695
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Discovery Projects
STrAtegies for RelaTives (START) ARC Accelerator
相关策略 (START) ARC 加速器
  • 批准号:
    ES/Y011139/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Research Grant
Collaborative Research: Conference: Strategies to Mitigate Implicit Bias and Promote an Ethos of Care in the Research Enterprise: A Convening
协作研究:会议:减轻隐性偏见并促进研究企业关怀精神的策略:召开会议
  • 批准号:
    2324401
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Standard Grant
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Are family firms in Japan resilient to economic shock? Digging further by family types, management strategies, and earnings quality.
日本的家族企业能否抵御经济冲击?
  • 批准号:
    24K00297
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
日本の女性の政治参画推進策の現状分析―Non-quota strategiesに着目して
日本促进妇女参政措施现状分析——以非配额策略为中心
  • 批准号:
    24K15567
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gut immunity: Unraveling Mechanisms and Strategies for Neonatal Intestinal Disorder
肠道免疫:揭示新生儿肠道疾病的机制和策略
  • 批准号:
    502588
  • 财政年份:
    2024
  • 资助金额:
    $ 11.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了